FMT holds considerable promise as a therapy for recurrent CDI but well-designed, RCTs and long-term follow-up registries are still required. These are needed to identify the right patient, efficacy and safety profile of FMT before this approach can be widely advocated.
No takes yet. Share an insight, caveat, or question.
Kassam et al. (2013) studied this question.